Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT01510756 · TERMINATED
Trial details
- NCT number
- NCT01510756
- Sponsor
- Thomas Kipps
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2014-05-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.